Bile acids as regulatory molecules
暂无分享,去创建一个
P. Dent | P. Hylemon | S. Ren | G. Gil | W. Pandak | Huiping Zhou
[1] B. Staels,et al. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. , 2009, Biochemical pharmacology.
[2] S. Strom,et al. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression , 2009, Hepatology.
[3] B. Staels,et al. Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.
[4] B. Bouscarel,et al. Bile acids and signal transduction: role in glucose homeostasis. , 2008, Cellular signalling.
[5] T. Miloh,et al. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor , 2008, Hepatology.
[6] Xiaobo Li,et al. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway. , 2008, American journal of physiology. Endocrinology and metabolism.
[7] D. Hum,et al. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. , 2008, Molecular endocrinology.
[8] P. Luoma. Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis , 2008, European Journal of Clinical Pharmacology.
[9] S. Kliewer,et al. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. , 2008, Molecular endocrinology.
[10] A. Smrcka. G protein βγ subunits: Central mediators of G protein-coupled receptor signaling , 2008, Cellular and Molecular Life Sciences.
[11] K. Wikvall,et al. Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. , 2008, Current drug metabolism.
[12] P. Dawson,et al. The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis , 2008, Proceedings of the National Academy of Sciences.
[13] J. Auwerx,et al. Bile acids and the membrane bile acid receptor TGR5--connecting nutrition and metabolism. , 2008, Thyroid : official journal of the American Thyroid Association.
[14] J. Staudinger,et al. Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease. , 2008, Molecular pharmaceutics.
[15] N. Mitro,et al. The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol. , 2007, Pharmacology & therapeutics.
[16] Xiaobo Li,et al. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes. , 2007, Journal of lipid research.
[17] S. Kliewer,et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine Published, JLR Papers in Press, August 24, 2007. , 2007, Journal of Lipid Research.
[18] J. Auwerx,et al. Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1 , 2007, Molecular and Cellular Biology.
[19] N. Moore,et al. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. , 2007, Molecular endocrinology.
[20] Richard M. Eglen,et al. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development , 2007, Nature Reviews Drug Discovery.
[21] B. Staels,et al. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control , 2007, Current opinion in lipidology.
[22] P. Dent,et al. Conjugated Bile Acids Regulate Hepatocyte Glycogen Synthase Activity In Vitro and In Vivo via Gαi Signaling , 2007, Molecular Pharmacology.
[23] Min Jung Park,et al. Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha. , 2007, The Biochemical journal.
[24] D. Häussinger,et al. The G‐protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells , 2007, Hepatology.
[25] J. Cha,et al. The Liver X Receptor (LXR) and Hepatic Lipogenesis , 2007, Journal of Biological Chemistry.
[26] D. Russell,et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. , 2007, Cell metabolism.
[27] P. Saha,et al. Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis. , 2006, Molecular endocrinology.
[28] H. Miyoshi,et al. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. , 2006, The Journal of endocrinology.
[29] J. Chiang,et al. Bile acids and cytokines inhibit the human cholesterol 7α‐hydroxylase gene via the JNK/c‐jun pathway in human liver cells , 2006 .
[30] Ke Ma,et al. Farnesoid X receptor is essential for normal glucose homeostasis. , 2006, The Journal of clinical investigation.
[31] S. Kliewer,et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] Dae-Joong Kang,et al. Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.
[33] J. Auwerx,et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.
[34] Timothy M Willson,et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Chiang,et al. Glucagon and cAMP inhibit cholesterol 7α‐hydroxylase (CYP7a1) gene expression in human hepatocytes: Discordant regulation of bile acid synthesis and gluconeogenesis , 2006, Hepatology.
[36] P. Dawson,et al. OSTα‐OSTβ: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia , 2005 .
[37] S. Spiegel,et al. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes , 2005, Hepatology.
[38] S. Kliewer,et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.
[39] Folkert Kuipers,et al. The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition* , 2005, Journal of Biological Chemistry.
[40] Y. Nabeshima,et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. , 2005, The Journal of clinical investigation.
[41] C. Tomasetto,et al. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals , 2005, Journal of Cell Science.
[42] Richard R. Neubig,et al. International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.
[43] P. Hylemon,et al. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. , 2005, Biochimica et biophysica acta.
[44] P. Dawson,et al. The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.
[45] P. Hylemon,et al. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. , 2005, Journal of clinical gastroenterology.
[46] P. Hylemon,et al. Overexpression of cholesterol transporter StAR increases In Vivo rates of bile acid synthesis in the rat and mouse , 2004, Hepatology.
[47] A. Fukamizu,et al. Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.
[48] Sander M Houten,et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. , 2004, The Journal of clinical investigation.
[49] S. Payne,et al. Deoxycholic Acid Activates the c-Jun N-terminal Kinase Pathway via FAS Receptor Activation in Primary Hepatocytes , 2004, Journal of Biological Chemistry.
[50] P. Dent,et al. Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes , 2004, Hepatology.
[51] P. Edwards,et al. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR , 2004 .
[52] J. Raufman,et al. REVIEW: Activation of Muscarinic Receptor Signaling by Bile Acids: Physiological and Medical Implications , 2003, Digestive Diseases and Sciences.
[53] Bruno Stieger,et al. Enterohepatic bile salt transporters in normal physiology and liver disease. , 2004, Gastroenterology.
[54] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[55] D. Russell. The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.
[56] Giovanni Galli,et al. Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.
[57] M. Norlin,et al. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. , 2003, Journal of lipid research.
[58] S. Kliewer,et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.
[59] Jung-Hwan Yoon,et al. Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[60] Masataka Harada,et al. A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.
[61] J. Raufman,et al. Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry. , 2002, European journal of pharmacology.
[62] P. Hylemon,et al. Transport of Cholesterol into Mitochondria Is Rate-limiting for Bile Acid Synthesis via the Alternative Pathway in Primary Rat Hepatocytes* , 2002, The Journal of Biological Chemistry.
[63] Takao Nakamura,et al. Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.
[64] M. Haussler,et al. Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.
[65] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[66] P. Dent,et al. Inhibition of the MAPK and PI3K pathways enhances UDCA‐induced apoptosis in primary rodent hepatocytes , 2002, Hepatology.
[67] G. Gores,et al. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. , 2002, Gastroenterology.
[68] P. Dent,et al. Activation of the Raf‐1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes , 2002, Hepatology.
[69] T. Willson,et al. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. , 2001, Molecular endocrinology.
[70] P. Fisher,et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. , 2001, Molecular biology of the cell.
[71] J. Boyer,et al. Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[72] P. Dent,et al. Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[73] T. Willson,et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Evans,et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[75] D. Mangelsdorf,et al. Role of LXRs in control of lipogenesis. , 2000, Genes & development.
[76] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[77] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[78] L. Moore,et al. Identification of a chemical tool for the orphan nuclear receptor FXR. , 2000, Journal of medicinal chemistry.
[79] Roger A. Davis,et al. Bile Acid Induction of Cytokine Expression by Macrophages Correlates with Repression of Hepatic Cholesterol 7α-Hydroxylase* , 2000, The Journal of Biological Chemistry.
[80] C. Deng,et al. Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.
[81] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[82] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[83] Jasmine Chen,et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.
[84] J. Raufman,et al. Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from guinea pig stomach. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[85] R. W. Daniel,et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[86] R. Stravitz,et al. Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. , 1997, Journal of lipid research.
[87] R. Stravitz,et al. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. , 1996, The American journal of physiology.
[88] J. Lord,et al. Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids , 1995, International journal of cancer.
[89] P. Dawson,et al. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. , 1994, The Journal of biological chemistry.
[90] J. Sjövall,et al. Potential bile acid precursors in plasma--possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. , 1990, Journal of steroid biochemistry.
[91] F. DeRubertis,et al. Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. , 1987, The Journal of clinical investigation.
[92] F. Iber. Hepatology: A Textbook of Liver Disease , 1983 .
[93] K. Einarsson,et al. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. , 1978, Journal of lipid research.
[94] W. Hardison. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. , 1978, Gastroenterology.
[95] S. Grundy,et al. Changes in plasma triglyceride metabolism during withdrawal of bile. , 1976, Metabolism: clinical and experimental.
[96] S. Grundy,et al. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. , 1971, The Journal of laboratory and clinical medicine.